Investigating incidence, severity and risk factors for COVID-19 in BAME and Migrant groups to inform public health action.

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:42 publications

Grant number: MR/V028375/1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $936,099.22
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Dr. Robert Aldridge
  • Research Location

    United Kingdom
  • Lead Research Institution

    University College London
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Internally Displaced and Migrants

  • Occupations of Interest

    Unspecified

Abstract

The severity of illness from COVID-19 and risk of death appears to be increased in minority ethnic and migrant groups. Most of our information about COVID-19 is from people who are ill enough to have to go to hospital. This means we have an incomplete understanding of the infection and how we can tackle it in the community. Our first study will solve this problem by including more minority ethnic and migrant communities in our existing study, Virus Watch, which is studying COVID-19 in the community. Each week we will ask 12,000 people to report any symptoms. We will test a subset any time they have symptoms, and we will perform antibody blood tests (to find evidence of ever having the infection) at the start and end of the study. We will be able to explore why COVID-19 affects BAME and migrant communities differently. Our second study will use health records for nearly all non-EU migrants and refugees that arrived in the UK since 2015. We will use these data to examine how often these groups get diagnosed, hospitalised and die from COVID-19 and investigate whether their existing health conditions and socioeconomic circumstances affect their risk of COVID-19.

Publicationslinked via Europe PMC

Anti-nucleocapsid and anti-spike antibody trajectories in people with post-covid condition versus acute-only infections: a nested longitudinal case-control study within the Virus Watch prospective cohort.

Long-term outcomes of SARS-CoV-2 variants and other respiratory infections: evidence from the Virus Watch prospective cohort in England.

The incidence of COVID-19-related hospitalisation in migrants in the UK: Findings from the Virus Watch prospective community cohort study.

Linking migration and hospital data in England: linkage process and evaluation of bias.

Eyeglasses and risk of COVID-19 transmission-analysis of the Virus Watch Community Cohort study.

COVID-19 vaccination coverage for half a million non-EU migrants and refugees in England.

Deprivation, essential and non-essential activities and SARS-CoV-2 infection following the lifting of national public health restrictions in England and Wales.

Cohort Profile: Virus Watch-understanding community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviour.

Deprivation, essential and non-essential activities and SARS-CoV-2 infection following the lifting of national public health restrictions in England and Wales